Orion Forecasts Strong 2026 as Cancer Drug Nubeqa Eyes One Billion Euro Milestone

Espoo, Wednesday, 14 January 2026.
Orion projects its prostate cancer treatment could surpass €1 billion in annual sales, signaling a shift to blockbuster status and underpinning a robust 2026 financial outlook.